Admit Therapeutics

Admit Therapeutics company information, Employees & Contact Information

ADmit Therapeutics is biotech company focused on the commerzalitation of the MAP-AD Test, the first epigenetic IVD Test for the prognosis of Alzheimer’s disease

Company Details

Employees
13
Founded
-
Address
Crta. Laureà Miró, 408-410, Sant Feliu De Llobregat,barcelona 08980,spain
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Sant Feliu de Llobregat, Barcelona
Looking for a particular Admit Therapeutics employee's phone or email?

Admit Therapeutics Questions

News

Mitochondrial methylcytosines as blood-based biomarkers for Alzheimer’s disease dementia prognosis - ScienceDirect.com

Mitochondrial methylcytosines as blood-based biomarkers for Alzheimer’s disease dementia prognosis ScienceDirect.com

Catalan researchers create a test to predict Alzheimer's - Diari ARA

Catalan researchers create a test to predict Alzheimer's Diari ARA

Eversheds Sutherland advises on the financing round of ADmit Therapeutics - Iberian Lawyer

Eversheds Sutherland advises on the financing round of ADmit Therapeutics Iberian Lawyer

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant